186 related articles for article (PubMed ID: 12727812)
1. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of the selectivity of KTS-disintegrins for the alpha1beta1 integrin.
Kisiel DG; Calvete JJ; Katzhendler J; Fertala A; Lazarovici P; Marcinkiewicz C
FEBS Lett; 2004 Nov; 577(3):478-82. PubMed ID: 15556632
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin.
Brown MC; Eble JA; Calvete JJ; Marcinkiewicz C
Biochem J; 2009 Jan; 417(1):95-101. PubMed ID: 18774946
[TBL] [Abstract][Full Text] [Related]
4. Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa.
Moreno-Murciano MP; Monleón D; Calvete JJ; Celda B; Marcinkiewicz C
Protein Sci; 2003 Feb; 12(2):366-71. PubMed ID: 12538900
[TBL] [Abstract][Full Text] [Related]
5. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
[TBL] [Abstract][Full Text] [Related]
6. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
[TBL] [Abstract][Full Text] [Related]
7. The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.
Ghazaryan N; Movsisyan N; Macedo JC; Vaz S; Ayvazyan N; Pardo L; Logarinho E
Invest New Drugs; 2019 Oct; 37(5):1044-1051. PubMed ID: 30680583
[TBL] [Abstract][Full Text] [Related]
8. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
9. Vimocin and vidapin, cyclic KTS peptides, are dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity.
Momic T; Katzehendler J; Benny O; Lahiani A; Cohen G; Noy E; Senderowitz H; Eble JA; Marcinkiewicz C; Lazarovici P
J Pharmacol Exp Ther; 2014 Sep; 350(3):506-19. PubMed ID: 24939421
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
[TBL] [Abstract][Full Text] [Related]
11. Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth.
Brown MC; Staniszewska I; Del Valle L; Tuszynski GP; Marcinkiewicz C
Int J Cancer; 2008 Nov; 123(9):2195-203. PubMed ID: 18712720
[TBL] [Abstract][Full Text] [Related]
12. Leberagin-C, A disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion.
Limam I; Bazaa A; Srairi-Abid N; Taboubi S; Jebali J; Zouari-Kessentini R; Kallech-Ziri O; Mejdoub H; Hammami A; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2010 Mar; 29(2):117-26. PubMed ID: 19808093
[TBL] [Abstract][Full Text] [Related]
13. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
[TBL] [Abstract][Full Text] [Related]
14. The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion.
Souza DH; Iemma MR; Ferreira LL; Faria JP; Oliva ML; Zingali RB; Niewiarowski S; Selistre-de-Araujo HS
Arch Biochem Biophys; 2000 Dec; 384(2):341-50. PubMed ID: 11368322
[TBL] [Abstract][Full Text] [Related]
15. KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin.
Calvete JJ; Marcinkiewicz C; Sanz L
Curr Pharm Des; 2007; 13(28):2853-9. PubMed ID: 17979730
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma.
Bazan-Socha S; Bukiej A; Pulka G; Marcinkiewicz C; Musial J
Clin Exp Allergy; 2006 Sep; 36(9):1184-91. PubMed ID: 16961719
[TBL] [Abstract][Full Text] [Related]
17. Leucurogin, a new recombinant disintegrin cloned from Bothrops leucurus (white-tailed-jararaca) with potent activity upon platelet aggregation and tumor growth.
Higuchi DA; Almeida MC; Barros CC; Sanchez EF; Pesquero PR; Lang EA; Samaan M; Araujo RC; Pesquero JB; Pesquero JL
Toxicon; 2011 Jul; 58(1):123-9. PubMed ID: 21641921
[TBL] [Abstract][Full Text] [Related]
18. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
[TBL] [Abstract][Full Text] [Related]
19. cDNA cloning and functional expression of jerdostatin, a novel RTS-disintegrin from Trimeresurus jerdonii and a specific antagonist of the alpha1beta1 integrin.
Sanz L; Chen RQ; Pérez A; Hilario R; Juárez P; Marcinkiewicz C; Monleón D; Celda B; Xiong YL; Pérez-Payá E; Calvete JJ
J Biol Chem; 2005 Dec; 280(49):40714-22. PubMed ID: 16215260
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin.
Hunter EJ; Hamaia SW; Gullberg D; Malcor JD; Farndale RW
Toxicol Appl Pharmacol; 2021 Oct; 428():115669. PubMed ID: 34363821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
